ArticleTranslational cancer research2025

Combining anti-metabolic treatments with the repurposing of eribulin for glioblastoma: a clinical opportunity?

Étienne Audet-Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.